Skip to main content
. 2019 Dec 11;7(4):222–241. doi: 10.5599/admet.733

Scheme 1.

Scheme 1

Initially identified fragment binder (compound 1) and key compounds (2 – 5) that were made in the search for a cell active compound to probe the biology associated with PHGDH as a drug target.